News from NIAID-Supported Institutions
National Institute of Allergy and Infectious Diseases sent this bulletin at 01/29/2015 04:37 PM EST
Leading Research to Understand, Treat, and Prevent Infectious, Immunologic, and Allergic Diseases |
    Visit us on the Web |
Here’s your periodic update on News from NIAID-Supported Institutions. The following links will take you to the institution’s press release:
Know Your Enemy: Combating Whooping Cough Requires Informed Vaccine Booster Schedules
January 19, 2015—University of Michigan
January 19, 2015—University of Michigan
Rare Mutations Do Not Explain “Missing Heritability” in Asthma
January 16, 2015—University of Chicago
"Universal Flu Vaccine" May Be Closer Than We Think, Says Mac Researcher
January 15, 2015—McMaster University
Tumor Suppressor Protein Helps Immune System Stay Balanced
January 15, 2015—St. Jude Children’s Research Hospital
Long-Acting Drug Effectively Prevents HIV-Like Infection in Monkeys
January 15, 2015—The Rockefeller University
Vaccine-Induced CD4 T Cells Lead to Adverse Effect in a Mouse Model of Infection
January 15, 2015—Beth Israel Deaconess Medical Center
Contract Research Organization WCCT Global Announced Collaboration Agreement with the NIAID for Influenza Challenge Research
January 15, 2015—WCCT Global
3D Systems Partners with National Institutes of Health (NIH) to Advance Medical Innovations Through 3D Printing
January 15, 2015—3D Systems
Possible Treatments Identified for Highly Contagious Stomach Virus
January 13, 2015—Washington University School of Medicine in St. Louis
Study Links Common Human Protein to Adverse Parasitic Worm Infections
January 8, 2015—University of California, Riverside
January 8, 2015—University of California, Riverside
New Approach May Lead to Inhalable Vaccines for Influenza, Pneumonia
January 7, 2015—University of North Carolina at Chapel Hill
Newly Discovered Antibiotic Kills Pathogens Without Resistance
January 7, 2015—Northeastern University
Johnson & Johnson Announces Start of Phase 1 Clinical Trial of Ebola Vaccine Regimen
Jan. 6, 2015—Johnson & Johnson
Bavarian Nordic Announces Initiation of Phase 1 Clinical Trial for the Ebola Vaccine Regimen of MVA-BN® Filo and Janssen’s AdVac® Technology
January 6, 2015—Bavarian Nordic
Nearly Half-Million Dollar NIH Grant Awarded to Study Widespread Virus Affecting Infants
January 6, 2015—Ohio University Heritage College of Osteopathic Medicine
Soligenix Announces Positive Preliminary Nonclinical Results in Macrophage Activation Syndrome
January 5, 2015—Soligenix, Inc.
Fat Isn’t All Bad: Skin Adipocytes Help Protect Against Infections
January 5, 2015—University of California, San Diego School of Medicine
January 5, 2015—University of California, San Diego School of Medicine
HIV Vaccines Should Avoid Viral Target Cells, Primate Model Study Suggests
January 2, 2015—Emory University
Purdue Research Suggests Approach to Treat Virus Causing Respiratory Illness, Possible Paralysis in Children
January 1, 2015—Purdue University
These news releases were issued by organizations supported by NIAID. To receive NIAID-issued news releases, update your subscription preferences by selecting “News Releases.”
If you would like to see your NIAID-supported research featured here, contact us at niaidnews@niaid.nih.gov.
